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Migraine is an episodic brain disorder with disabling
attacks of headache that are associated with nausea, vomit-
ing, and hypersensitivity to light, sound, and smell.
According to major criteria of the International Classifica-
tion of Headache Disorders (ICHD-II) from the Interna-
tional Headache Society (IHS), migraine is divided into
two main subtypes that are based on the absence
(migraine without aura, MO) or presence (migraine with
aura, MA) of an aura. Migraine has a profound effect on
wellbeing and general functioning, not only during attacks,
but also in terms of work performance, family and social
relationships, and, mainly in children, school achievement,
thus explaining why the WHO expert panel rates migraine
among the most disabling and costly chronic disorders.
There is a strong genetic component in migraine as evi-
denced by observations that the disorder runs in families
and that about 50% of the patients have close relatives also
affected by a similar condition. However, migraine risk is
also conferred by environmental factors and epidemiologi-
cal evidence suggesting a tight gene-environment interac-
tion (endogenous or exogenous), among which several
predisposing or triggering factors have been defined.
In the past decades, our growing understanding of the
genetic contributions in migraine disorders has been
translated in better knowledge of the pathophysiology but
needs to grow further and to be translated into more
effective treatments. Indeed, several genes involved in syn-
dromic and monogenic forms of migraine have been
defined, allowing a significant contribution to the mechan-
isms generating the attacks, but the timing and specific
contribution of secondary hits remain largely unclear.
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